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The patient was a 24-year-old male who visited our University Hospital complaining of 
chest pain, and chest computed tomography revealed multiple bilateral nodules.  The 
chest pain disappeared almost immediately, but the tumor underwent no changes during 
the 3 years of follow-up observations.  We used a thoracoscope to perform a partial lung 
resection of a nodule that reached a maximum diameter of 9 mm for the purpose of ob-
taining a definite diagnosis.  From the pathological findings, the patient was diagnosed 
to have pulmonary sclerosing hemangioma in which circular tumor cells lacking nuclear 
atypia rose to papillary hyperplasia.  The mindbomb homolog-1 positive rate (MIB-1 
index) of the tumor cells was less than 1%, and it is believed to have a poor proliferation 
activity.  Pulmonary sclerosing hemangioma is predominantly found in cases of middle-
aged female patients and occurs unilaterally.  Cases of bilateral multiple forms in young 
males are extremely rare.  Some cases of enlargement, metastasis and relapse have also 
been reported, so in the future, careful follow-up is required. 
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Cases of pulmonary sclerosing hemangioma are 
commonly found to occur unilaterally in middle-
aged females.  In this study, we experienced an 
extremely rare case of bilateral multiple pulmo-
nary sclerosing hemangioma in a young male, 
and we hereby present our results, together with a 
number of bibliographical considerations.
Patient Report
The patient was a 24-year-old male.  By chest 
computed tomographic scan performed to address 
his major complaint of chest pain, well-circum-
scribed multiple small circular nodules with a 
maximum diameter of 9 mm were observed in 
both lungs.  There were no differences between 
the right and left nodules, but they were mostly 
found in the lower lobe, and their interiors were 
even and showed no calcification.  No contrast 
effects were observed (Figs. 1A and B).  The 
chest pain disappeared almost immediately, but 
there were no changes in the number or the size 
of the nodules during the 3 years of follow-up 
observation.  All inflammatory reactions and tu-
mor markers showed normal ranges in the blood 
examinations, and the patient tested negative 
for aspergillus antigen and cryptococcal antigen 
analyses.  Upon obtaining the patient’s informed 
consent, we performed surgery to obtain a defi-
nite diagnosis, because the patient was still young 
and we were unable to rule out the possibility of 
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a malignant tumor or an infectious lesion.  Tho-
racoscopic observations identified multiple small 
nodules with the same appearance that were 3 to 
5 mm in size immediately under the pleural mem-
brane, so using a thoracoscope, we performed the 
partial lung resection of a nodule with the largest 
diameter, located in the right median lobe.  The 
resected tumor was 9  8 mm in size with a flat, 
smooth surface and a solid interior (Fig. 2).  From 
the histopathological findings, the patient was 
diagnosed with pulmonary sclerosing heman-
gioma, because the circular tumor cells that had 
poor nuclear atypia rose to papillary hyperplasia 
(Figs. 3A and B).  In an immunohistochemical 
test, thyroid transcription factor-1 and surfactant 
aproprotein A tested positive, and the mindbomb 
homolog-1 positive rate (MIB-1 index) was less 
than 1%.  No significant lesion has been observed, 
with respect to the size and the number of the re-
maining tumors, 6 months after surgery.  
Discussion
Pulmonary sclerosing hemangioma was first 
reported by Liebow and Hubble in 1956.  The 
frequency of the occurrence thereof accounted 
for approximately 1% of all pulmonary tumors, 
following hamartoma among the benign tumors, 
but more than 80% of all cases occur in female 
patients who are mostly in their 40s (Iyoda et al., 
2004).  The majority of these cases are asymp-
tomatic, but coughing, chest pain and bloody 
sputum are also observed in symptomatic cases 
(Kaltzenstein et al., 1983; Iyoda et al., 2004).  There 
are various views regarding the histogenesis such 
Fig. 1.  Chest computed tomographic scan reveals well-circumscribed multiple small circular nodules (arrows) in 
both lungs (A).  They are mostly found in the lower lobe (A).  A nodule with the maximum diameter of 9 mm (arrow) 
is observed in the right middle lobe (B). 
Fig. 2.  The resected tumor (arrow) in the right middle 
lobe is 9  8 mm in size with a flat, smooth surface and a 
solid interior.
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less than 1%, and it is believed to have a low pro-
liferation activity (Filiz et al., 2007).  However, 
this was a case of early onset:  we therefore need 
to perform careful follow-up examinations in the 
future.
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